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ABSTRACT
A number of states currently rely on Eleventh Amendment immunity to defend against
infringement actions by the patentees during research and development of new
technologies. Some of these states then evoke the federal patent system to exclude
private parties from infringing state patented subject matter. Ultimately, states enjoy all
of the benefits of the federal patent system but states are not limited by any of its
restrictions. This comment proposes a remedy to the states' unfair tactical advantage of
using the federal patent system as both a shield and a sword.
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INTRODUCTION

In the 1998 action film, Armageddon, Billy Bob Thornton's character, NASA
Executive Director Truman, charges Bruce Willis's character, Oil Driller Harry
Stamper, with saving the world.1 Truman has recruited Stamper to save the planet
from an impending collision with an asteroid.2 Truman takes Stamper to the drill rig
that NASA's Design Engineer, Jason Isaacs's character, Ronald Qunicy, has built to
accomplish the mission, hoping that Stamper can assist in solving some of the
3
problems with the rig.
Truman: You might recognize the rig.
Stamper: Well, I guess I should recognize it. It's my design. What, did you
steal a key to the patent office?
Truman: Yeah, basically.
Stamper: Let me get this straight, I got pulled off an oil rig, flown half way
around the world because you stole my drill design, couldn't read
the plans right, and did a piss poor job of putting it together?
4
Technically, patents don't apply to outer space.
Quincy:
While most state agencies are not saving the planet, many are currently
infringing patents. For example, the California Department of Health Services
("DHS") is infringing one of Biomedical Patent Management Corporation's ("BPMC")
patents covering a method of prenatal screening for fetal chromosomal
abnormalities. 5 DHS successfully asserted the affirmative defense of sovereign
immunity under the Eleventh Amendment 6 in a decision by the United States Court
* J.D.
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2 Id.
3 Id.
Stamper then listens to Truman's plan for sending astronauts to the asteroid that is
headed toward an impact with earth in the near future. Id.
4 Id. Quincy originally began construction on Stamper's drill rig design for a mission to land on
Mars to do some exploratory drilling. Id.
Quincy begins to explain that the United States
government is free to infringe any and all patents to pursue further exploration into outer space. Id.
After finding out that an asteroid capable of sending the earth into another ice age was heading
toward earth, NASA changed the plans for the rig. Id. The set of two identical rigs was now
destined to help save the planet. Id.
5 Biomedical Patent Mgmt. Corp. v. Cal., Dep't of Health Servs., 505 F.3d 1328, 1330 (Fed. Cir.
2007), petition for cert. fled, 76 U.S.L.W. 3410 (U.S. Jan. 22, 2008) (No. 07-956).
(3U.S. CONST. amend. XI.
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of Appeals for the Federal Circuit ("CAFC"). 7 Even though state agencies are
immune from patent infringement, this immunity has not stopped those agencies
from enforcing patent rights against private companies.
This comment addresses issues regarding state agencies using the patent
system to enforce patents while asserting sovereign immunity under the Eleventh
Amendment to protect against infringement actions brought by private parties.
Section I describes the relevant history of the Eleventh Amendment and its
application to current patent law issues. Additionally, Section I explores the
different ways that state agencies have benefited from Eleventh Amendment
protection.
Lastly, the section discusses the limits of Eleventh Amendment
protection.
Section II analyzes whether states can take actions that waive sovereign
immunity under the Eleventh Amendment and what specific actions constitute a
waiver of that protection.
Section III proposes a solution to state agencies'
manipulation of the federal patent system as both a shield and a sword. In other
words, state agencies' use of Eleventh Amendment creates an unfair advantage for
state agencies by protecting them from liability for infringing patents while allowing
them to manipulate the federal patent system to enforce state patent rights.

I.BACKGROUND
A. Jurisdiction
The Eleventh Amendment 8 was enacted shortly after the 1793 Supreme Court
decision in Chisholm v. Georgia.9 The United States Supreme Court held, relying on
Article III of the Constitution, 10 that a citizen of another state could sue an
unconsenting state in federal court.1 1 Consequently, Congress became concerned
that states would be liable in suits concerning outstanding Revolutionary War
debts. 12 States ratified the Eleventh Amendment shortly after the Chisholm
7 Biomedial
Patent, 505 F.3d at 1330-31. The CAFC concluded that the inconsistency that
would arise from allowing DHS to assert sovereign immunity was not substantial enough to divert
from the court's precedent with respect to sovereign immunity. Id. at 1341. Waiver of sovereign
immunity generally does not extend to a separate lawsuit. Id. The state's participation in the
federal patent system does not itself waive sovereign immunity rights. Id at 1343.
8U.S. CONST. amend XI. The Eleventh Amendment was proposed by Congress on March 4,
1794 and was ratified by the States on February 7, 1795.
2 U.S. 419 (1793). "A State is suable by citizens of another State." Id.at 479. The opinion
mentioned possible exceptions to this decision. Id. For example, states could not be sued for debt
incurred before the ratification of the U.S. Constitution. Id.
10U.S. CONST. art. III, § 2, cl. 1, amended by U.S. Const. amend XI. ("The judicial Power shall
extend to all Cases, in Law and Equity, arising under this Constitution, ... -to Controversies
between two or more States;-between a State and Citizens of another State ....
").
11Chisholm, 2 U.S. at 479 ("The extension of judiciary power of the United States to such
controversies, appears to me to be wise ... because it leaves not even the most obscure and
friendless citizen without means of obtaining justice from a neighbouring State.").
12

ERWIN

CHEMERINSKY,

FEDERAL JURISDICTION 391 (3d ed. 1999).

The prospect of States

potential to be sued in federal court to collect debts incurred during the Revolutionary War caused
great concern. Id. States had incurred substantial debts during the war. Id. According to George
Mason and Patrick Henry Article III of the constitution should have addressed the individual suing

[8:1 2008]

The John Marshall Review of Intellectual Property Law

decision, and it precluded individuals from suing states to recover debts from the
Revolutionary War. 13
The language of the Eleventh Amendment specifically
provides for state protection in cases based on diversity. 14 Additionally, subsequent
Supreme Court decisions have expanded this protection to include suits with federal
question jurisdiction. 15
Patent claims may not be litigated in state court because 28 U.S.C. § 1338
establishes that federal courts are the only proper venue to bring an action related to
patents. 16 Additionally, the CAFC has jurisdiction over all patent issues.1 7 Thus, it
follows that patent claims may not be litigated in state courts.
Currently, the Eleventh Amendment precludes any party from bringing a suit
against a state agency in federal court, and 28 U.S.C. § 1338 precludes the party
18
from bringing any action relating to patents in any court other than a federal court.
Therefore, these two laws insulate state agencies with unequivocal immunity from
patent infringement claims. 19 Ultimately, the current loophole leaves individuals
with potential patent infringement causes of action against a state agency without a
proper court in which to bring an action.20

a state issue. Id. at 391-92. While the United States Constitution was being drafted, a number of
individuals expressed the very concerns that the Eleventh Amendment was later needed to remedy.

Id.
13Id.

at 395-96.
U.S. CONST. amend. XI ("The Judicial power of the United States shall not be construed to
extend to any suit in law or equity, commenced or prosecuted against one of the United States by
Citizens of another State, or by Citizens or Subjects of any Foreign State.").
15 Fla. Prepaid Postsecondary Educ. Expense Bd. v. Coll. Sav. Bank, 527 U.S. 627, 634-35
(1999) [hereinafter Florid Prepaid]. Even though the language in Article III appears to restrict the
Eleventh Amendment protection to diversity jurisdiction in the federal courts, the Court has
understood the language to include the same protection for federal question jurisdiction in federal
courts. Id. at 634. The Court views the Eleventh Amendment to codify the States' inherent
sovereign immunity for both diversity jurisdiction and federal question jurisdiction. Id. at 634-35.
1628 U.S.C. § 1338 (2006) ("The district courts shall have original jurisdiction of any civil
action arising under any Act of Congress relating to patents, plant variety protection, copyrights and
trademarks. Such jurisdiction shall be exclusive of the courts of the states in patent, plant variety
protection and copyright cases.").
17Id. § 1295 (2006). The CAFC has exclusive appellate jurisdiction in cases arising under 28
U.S.C. § 1338. Id.
18Florida Prepaid,527 U.S. at 651 (Stevens, J., dissenting). Patent litigation raises technical
issues that the state courts are not well equipped to address. Id. Even among federal circuit courts,
inconsistent holdings and a great divergence of interpretation of patent statutes lead to the creation
of the CAFC. Id. at 651 n.2.
1) Td. at 652. It was appropriate for Congress to abrogate state sovereign immunity with
respect to federal patent issues. Id. This is appropriate in order to close a potential loophole that
would allow states to use the federal patent system as both a shield and a sword. Id. This would
necessarily decrease the efficacy of the process afforded to patent holders. Id.
14

20 Id.
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B. Waiver of Eleventh Amendment Protection
Historically, courts held states, like private citizens, liable for infringement of
intellectual property rights. 2 1 Case law, however, has evolved to allow states to
defend against infringement actions brought by private citizens by invoking Eleventh
Amendment sovereign immunity.

22

Currently, states can enjoy an Eleventh Amendment defense against private
parties under most circumstances. Some circumstances, however, prevent states
from asserting Eleventh Amendment rights.

1. Congressionally-CreatedState Waiver
One situation that prevents states from asserting Eleventh Amendment rights is
when Congress enacts legislation preventing the defense. 23 For example, in 1985,
the Supreme Court determined that states do not waive Eleventh Amendment
immunity in federal court unless Congress, by statute, explicitly declares its intent to
abrogate

the

state's sovereign

immunity. 24

In

Atascadero State Hospital v.

25

Scanlon, the Supreme Court held that the state of California did not waive its
sovereign immunity by adopting the Rehabilitation Act of 1973 or by receiving funds
under the Act.26 Not long after the Supreme Court's decision in Atascadero,
21 Mills Music, Inc. v. Ariz., 591 F.2d 1278, 1285 (9th Cir. 1979). The holding provided that a
state may not infringe the federally protected rights of the copyright holder and then avoid the
federal system of statutory protections. Id. at 1286. The United States Court of Appeals for the
Ninth Circuit stated that, "the Eleventh Amendment's sovereign immunity does not permit the state
to nullify the rights reserved and protected by Congress, acting pursuant to the Copyright and
Patent Clause." Id. The State of Arizona was liable for copyright infringement because it decided to
use a musical composition owned by Mills Music Inc., "Happiness Is", for a theme song to the
Arizona state fair in 1971. Id. at 1280. After Mills Music won the suit, the court also awarded it
$3,500 in attorney's fees in connection with the appeal. Id. at 1287.
22 See FloridaPrepaid,527 U.S. at 636-37 (discussing the previous holdings of Seminole Tribe
ofFla. v. Florida,517 U.S. 44 (1996), and Fitzpatrick v. Bitzer 427 U.S. 445 (1976)).
23 But see id. at 636-37; Coll. Savings Bank v. Fla. Prepaid Postsecondary Educ. Expense Bd.,
527 U.S. 666, 675 (1999) [hereinafter College Savings Bank].
24 Atascadero State Hosp. v. Scanlon, 473 U.S. 234, 241 (1985). The Court expressed concern
about the balance of power between the Federal and State Government:
[B]ecause
the Eleventh Amendment implicates
the
fundamental
constitutional balance between Federal Government and the States, this Court
consistently has held that these exceptions apply only when certain specific
conditions are met. Thus, we have held that a State will be deemed to have
waived its immunity "only where stated 'by the most express language or by such
overwhelming implications from the text as will leave no room for any other
reasonable construction."'
Id. at 238-40 (quoting Edelman v. Jordan, 415 U.S. 651, 673 (1974)).
25 473 U.S. 234 (1985).
26 Id. at 246-47. A statute must specifically indicate that the state is willing to be sued in
federal court to waive sovereign immunity. Id. at 241. In Ataseadero, an individual attempted to
bring an action against a state hospital under the Rehabilitation Act of 1973. Id. at 236. The
Supreme Court held that the Rehabilitation Act did not unequivocally abrogate sovereign immunity
for a state in an action. Id. at 247. Therefore, the state hospital was able to successfully assert the
affirmative defense of sovereign immunity. Id.
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Congress passed the Patent and Plant Variety Protection Remedy Clarification Act
("Patent Remedy Act")2 7 and the Trademark Remedy Clarification Act ("TRCA") 28 in
an attempt to abrogate the states' Eleventh Amendment Sovereign Immunity with
29
respect to patent and trademark actions against states.
In Florida Prepaid Postseeondary Education Expense Board v. College &
Savings Bank, 30 however, the Supreme Court ruled that Congress did not have the
power to abrogate sovereign immunity under Article I Constitutional Powers or the
Fourteenth Amendment. 31 In the Florida Prepaid opinion, the Supreme Court
addressed the circumstances in which Congress could abrogate the sovereign
immunity of the states. 32 First, Congress must clearly and unequivocally express its
intent to abrogate sovereign immunity, 33 and second, Congress must have the
authority to abrogate sovereign immunity. 34 In FloridaPrepaid,the Supreme Court

held that the Patent Remedy Act (a statute defining the liability of states,
27

35 U.S.C. § 271 (2006).

28

15 U.S.C. § 1122 (2006).

2) 35 U.S.C. § 271(h).
As used in this section, the term "whoever" includes any State, any
instrumentality of a State, and any officer or employee of a State or
instrumentality of a State acting in his official capacity. Any State, and any such
instrumentality, officer, or employee, shall be subject to the provisions of this title
in the same manner and to the same extent as any nongovernmental entity.

Id.
Any State, instrumentality of a State or officer or employee of a state or
instrumentality of a state acting in his or her official capacity, shall not be
immune, under the eleventh amendment of the Constitution of the United States
or under any other doctrine of sovereign immunity, from suit in Federal court by
any person, including any governmental or nongovernmental entity for any
violation under this chapter.
15 U.S.C § 1122(b).
30 Florida Prepaid,527 U.S. at 636 ("Congress may not abrogate sovereign immunity under
Article I powers; hence the Patent Remedy Act cannot be sustained under either the Commerce
Clause or the Patent Clause.").
31 U.S. CONST. amend. XIV.
All persons born or naturalized in the United States, and subject to the
jurisdiction thereof, are citizens of the United States and of the State wherein
they reside. No State shall make or enforce any law which shall abridge the
privileges or immunities of citizens of the United States; nor shall any State
deprive any person of life, liberty, or property, without due process of law; nor
deny to any person within its jurisdiction the equal protection of the laws.
Id. FloridaPrepaidindicated that Congress may abrogate sovereign immunity through legislation if
the legislation can be viewed as a remedial or preventative legislation aimed at securing the
protections of the Fourteenth Amendment. FloridaPrepaid,527 U.S. at 639-40. Congress never
identified a pattern of infringement by the states that was depriving patent holders of their
property. Id. at 640. Congress also did not sufficiently establish that an infringement action was
the only proper relief for a patent holder for the infringement by the states. Id. Therefore, due
process was not sufficiently denied by depriving the patent holder a remedy against a state in patent
infringement actions under the Fourteenth Amendment. Id at 642-43.
32 FloridaPrepaid,527 U.S. at 634-35.
33 Id. at 634-35. The Court must establish "whether Congress has 'unequivocally expressed its
intent to abrogate the immunity."' Id. (quoting Seminole Tribe of Fla. v. Fla., 517 U.S. 44, 55
(1996)).
34 Id. at 635. The Court must establish, "whether Congress acted 'pursuant to a valid exercise
of power."' Id. (quoting Seminole Tribe, 517 U.S. at 55).
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instrumentalities of states, and state officials for infringement of patents) evinced a
clear intent to abrogate the states' Eleventh Amendment immunity. 3 5

The Court

held, however, that Congress did not have the authority to abrogate the states'
Eleventh Amendment sovereign immunity and, therefore, the Patent Remedy Act did
not abrogate the states' sovereign immunity for patent infringement cases against
state agencies. 36 Additionally, in a companion case, College Savings Bank v. Florida
PrepaidPostsecondaryExpense Board,37 the Court also stated that Congress did not
have the power to abrogate state sovereign immunity with respect to trademark
rights under the TRCA; the Court held that Congress did not, in fact, abrogate the
38
state's sovereign immunity.

2. Waiver by States'Affirmative Conduct
Although the Patent Remedy Act did not abrogate the states' sovereign
immunity, the Supreme Court had previously indicated, in Clark v. Barnard,39 that a
state agency waived Eleventh Amendment sovereign immunity by filing suit in
federal court. 40 The voluntary invocation of the federal court's jurisdiction is clearly
an action that indicates consent to federal court jurisdiction. 41 Therefore, a plaintiff
state agency that filed suit and consented to federal court jurisdiction waived its
42
Eleventh Amendment Sovereign Immunity.
A number of individual parties have brought suits against states after the more
recent holding in Ataseadero requiring a state to specifically indicate its willingness
to be sued in federal court. 43 The Supreme Court indicated that various forms of
affirmative conduct by a state established a state's voluntarily consent to federal
court jurisdiction. 44 For example, one way, with respect to a specific patent, a state
35 Id.
3

Id. at 647. The CAFC explained further:

[P]atents are property subject to the protections of the Due Process Clause
and that Congress' objective in enacting the Patent Remedy Act was permissible
because it sought to prevent States from depriving patent owners of this property

without due process. The court rejected Florida Prepaid's argument that it and
other States had not deprived patent owners of their property without due

process, and refused to "deny Congress the authority to subject all states to suit
for patent infringement in the federal courts, regardless of the extent of
procedural due process that may exist at any particular time."

Id. at 633 (quoting Coll. Sav. Bank v. Fla. Prepaid Postsecondary Educ. Expense Bd., 148 F.3d 1343,
1351 (Fed. Cir. 1998)).
'37
527 U.S. 666 (1999).
38Id.at 672, 691.
3)108 U.S. 436 (1883).
40Id.at 447.

Id.
Id. at 448.
4:3Baum Research and Dev. Co. v. Univ. of Mass., 503 F.3d 1367, 1367 (Fed. Cir. 2007); Vas
Cath Inc. v. Univ. of Mo., 473 F.3d 1376, 1376 (Fed. Cir. 2007); Tegic Commc'n Corp. v. Bd. of
Regents of the Univ. of Tex., 458 F.3d 1335, 1335 (Fed. Cir. 2006); Lapides v. Bd. of Regents of the
Univ. of Ga., 535 U.S. 613, 613 (2002).
44See, e.g., Lapides v. Bd. of Regents of the Univ. Sys. of Ga., 535 U.S. 613, 620 (2002)
(indicating that removal into federal court invokes federal court jurisdiction and waives Eleventh
41

42

Amendment sovereign immunity); Clark, 108 U.S. at 447 (indicating that filing suit in federal court
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waived Eleventh Amendment sovereign immunity was by initiating interference
proceedings. 45 Interference proceedings are a means of establishing proper priority
of patents. 46 The United States Patent and Trademark Office ("USPTO") oversees
interference proceedings when two or more patent applications claim the same
subject matter. 47 In Vas-Cath Inc. v. University ofMissourp448 Vas-Cath successfully
argued the University of Missouri ("UM") waived its sovereign immunity by
49
initiating an interference proceeding with respect to a patent issued to Vas-Cath.
In Vas-Cath, UM filed a patent application and Vas-Cath filed for an application
covering the same subject matter. 50 Then, the Vas-Cath patent issued before the UM
patent and UM subsequently filed for an interference proceeding to determine
priority for the patent. 51 The interference proceedings lasted over six years and
finally the USPTO determined that UM had priority for the invention. 52 Next, VasCath tried to appeal the USPTO's determination, and the district court dismissed the
appeal on Eleventh Amendment grounds. 53 The CAFC reversed the district court's
decision and held that UM had waived its Eleventh Amendment rights by initiating
interference proceedings. 54 The CAFC reasoned that UM could not both retain the
benefits of initiating the interference proceeding and bar the opposition from any
55
statutory right to review.
Additionally, the CAFC also clearly established that state entities are liable for
damages in compulsory counterclaim actions arising from state initiated declaratory
judgment actions. 56 For example, in Regents of the University of New Mexico v.
waived immunity); Baum Research and Dev. Co. v. Univ. of Mass., 503 F.3d 1367, 1372 (Fed. Cir.
2007) (indicating that a state agency may contractually waive sovereign immunity).
45Vas-Cath Inc. v. Univ. of Mo., 473 F.3d 1376, 1385 (Fed. Cir. 2007).
46 35 U.S.C. § 135 (2006). When two inventors claim the same subject matter, the USPTO
conducts an interference proceeding. Id. The proceeding involves an investigation focused on
identifying the actual conception date of the claimed invention for each of the inventors in the
proceeding. Id. The inventor that can establish an earlier conception date is awarded priority of
invention and is granted the right to patent the claim. Id.
47 Id.

48 473 F.3d 1376 (Fed. Cir. 2007). Finally, the CAFC court reversed the district court's ruling,
finding that Missouri waived its sovereign immunity by initiating the interference proceedings. Id.
at 1385.
49 Id.
5oId.at 1379.
51 d
52 Id.
53Id.at 1380.
54 Id. at 1385.
55Id.at 1384.
Nor do we think that the constitutionally grounded principal of state
sovereign immunity is any less robust where, as here, the asserted basis for
constructive waiver is conduct that the State realistically could choose to
abandon, that is undertaken for profit, that is traditionally performed by private
citizens and corporations, and that otherwise resembles the behavior of "market
participants."
Id. at 1381 (quoting College Savings Bank, 527 U.S. 666, 684 (1999)).
56 Regents of the Univ. of N.M. v. Knight, 321 F.3d 1111, 1125 (Fed. Cir. 2003). Dr. Knight was
employed by the University of New Mexico ('UNM") as a professor of biochemistry and medicine. Id.
at 1114. Knight was engaged in cancer research that led to the inventions related to beta-alethine
and vitaletheine. Id. The UNM filed a number of patents that named Knight as one of the
inventors. Id. The UNM filed five continuation-in-part applications, but Knight never assigned the
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Knight,57 the CAFC held that a state's filing for a declaratory judgment in a patent
case waived the state's Eleventh Amendment immunity from compulsory
counterclaims. 58 The CAFC granted damages for the counterclaims that arose from
the same patent issues raised by New Mexico in the declaratory judgment action
only. 59 New Mexico successfully defended all other claims not related to the initial
60
patent issue based on sovereign immunity.
Further, a state may also waive its sovereign immunity, with respect to a
specific patent, by agreeing to submit to federal jurisdiction in a licensing
agreement. 61 To illustrate, in Baum Research and Development Company v.
University ofMassaehusett, 62 the University of Massachusetts waived its sovereign
immunity by entering into a licensing contract with Baum Research for the rights to
use a Baum's patented devices.6 3
Eventually, the language of the licensing
agreement made it unequivocally clear that the university agreed to submit to the
64
jurisdiction of a federal court in Michigan as to disputes arising from the contract.

3. Waiver by Removal to FederalCourt
In addition to some affirmative conduct, the Supreme Court has indicated that a
state waived its Eleventh Amendment sovereign immunity by removing a case from
state court to federal court; in recent cases, a number of Circuit Courts of Appeals
continuation-in-part applications. Id. at 1115. Eventually the university laboratory that Knight
worked at lost funding and Knight was terminated. Id. After Knight was terminated, the UNM
granted Dovetail Technologies, Inc. a world-wide exclusive license for some of Knight's patents. -d.
Dovetail analyzed the patents and decided that they needed to be modified. Id. Subsequently, the
UNM submitted amendments to some of Knight's patents and Knight objected to the amendments,
and the amendments were accepted by the USPTO as not being directed to new matter. Id.
Dovetail filed a breach of warranty suit against the UNM because of Knight's refusal to assign the
UNM their rights in the continuation-in-part applications. Id. UNM then filed an action against
Knight seeking declaratory judgment, and ownership of the patents including the continuation-inpart applications. Id. Knight filed counterclaims against UNM that were dismissed by the district
court based on Eleventh Amendment Sovereign immunity. Id. at 1116. The CAFC finally reversed
the district court, holding that UNM had waived its sovereign immunity by filing the action for a
declaratory judgment with respect to the counterclaims that were compulsory to the initial UNM
action. Id. at 1128.
57 321 F.3d 1111 (Fed. Cir. 2003).
58 Id. at 1126.
59 Id. at 1128.
(3o d
61 Baum Research and Dev. Co. v. Univ. of Mass., 503 F.3d 1367, 1371 (Fed. Cir. 2007).
(32503 F.3d 1367 (Fed. Cir. 2007).
(3 Id. In 1998, the University executed a "Confidential License Agreement" with Baum to use
two of Baum's patented devises for testing baseball bats of varying construction. Id. at 1368. The
language in the agreement included, "this agreement will be construed, interpreted and applied
according to the laws of the State of Michigan and all parties agree to proper venue and hereby
submit to jurisdiction in the appropriate State or Federal Courts of Record sitting in the State of
Michigan." Id. at 1368-69. The University argued that the official from the University signatory to
the contract did not have authority to waive sovereign immunity for the University. _Id. at 1370.
The University next argued that the language was "vague" and that it did not unequivocally express
to the suit. _Id. The CAFC found both of these arguments unpersuasive and ruled against the
University. _Id. at 1371.
(34Id. at 1372.
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have encountered this issue and relied upon the holding in Lapides v. The Board of
Regents for the Universityof Georgia65 for guidance. In Lapides, a professor working
for the Georgia State University system filed an action in state court against the
system's Board of Regents ("Board") and university officials for placing sexual
harassment allegations in personnel files.6 6 The professor brought the action in state
court under state tort law and 42 U.S.C. § 1983.67 The Board then had the action
removed to federal court and subsequently tried to invoke Eleventh Amendment
sovereign immunity to dismiss the action.68 The Court held that the state waived its
immunity when it removed a case from state court to federal court. 69
Courts have applied the holding in Lapides consistently in areas of law other
than patent litigation. For example, in a discrimination case with parties disputing
the award of a contract, the United States Court of Appeals for the First Circuit held
in New Hampshire v. Ramsey7 0 that the state of New Hampshire consented to

federal court jurisdiction by removing the case to federal court. 71 New Hampshire
brought actions against the United States Department of Education ("USDOE") and
blind vendors.72
New Hampshire sought review of USDOE arbitration panel
decision, finding that New Hampshire violated Surface Transpiration Assistance Act
by failing to award the blind vendors vending machine contracts at interstate rest
stops. 73 The district court awarded the blind vendors approximately $900,000 in
compensatory damages as well as equitable relief.74 New Hampshire appealed the
ruling and the United States Court of Appeals for the First Circuit held that New
Hampshire had waived its immunity with respect to the equitable relief, but not with
respect to the damages awarded by the district court. 75 The First Circuit reasoned
that by initiating an action in federal court, New Hampshire waived sovereign
76
immunity under the Eleventh Amendment with respect to equitable relief.
Additionally, the court vacated the district court's award of damages to Blind
Vendors. 77
Some other circuit courts have not applied the Supreme Court's holding in
Lapides consistently. For example, the United States Court of Appeals for the
78
Fourth Circuit's holding in Stewart v. North Carolina
was not consistent with the
79
holding in Lapides.
In Stewart, the North Carolina Department of Correction
535 U.S. 613 (2002).
(36Lapides, 535 U.S. at 616.
G7 Jd
65

68 Id.

( Id. at 624.
70 366 F.3d 1 (1st Cir. 2004).
71Id. at 4.
72

Id.

73 Id.
7 Id.
75

Id.

77

Id.

78 393

F.3d 484 (4th Cir. 2005).

7) Compare Stewart v. North Carolina, 393 F.3d 484, 490 (4th Cir. 2005) (indicating that North

Carolina did not waive sovereign immunity by voluntarily removing an action to federal court
because it had not already consented to suit in its own court), with Lapides v. Bd. of Regents of the
Univ. Sys. of Ga., 535 U.S. 613, 624 (2002) (indicating that the State's action joining the removing of
the case to federal court waived its Eleventh Amendment immunity).
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("NCDOC") investigated Stewart, the chief of security of NCDOC, for potential
misconduct.80 The investigation report concluded that Stewart had been involved in
a double-billing scheme, and someone eventually leaked the report to the Raleigh
News & Observer, a local newspaper.8 1 Stewart then filed an action in state court
against NCDOC, officials of the NCDOC, and the state of North Carolina seeking
money damages under 24 U.S.C. §1983 and several other state law claims. 8 2 North
Carolina removed the case to federal court and promptly moved to dismiss all of the
claims based on Eleventh Amendment sovereign immunity.8 3 The Fourth Circuit
indicated that the district court read the waiver of Eleventh Amendment sovereign
immunity in Lapides too broadly, reversed the district court, and held that North
Carolina had not waived its sovereign immunity by removing the case to federal
4

court.8

4. A Focus on State ' Voluntary Submission to FederalCourt Jurisdiction
As noted above, the focus of state waiver analysis is a state's voluntary
submission to federal court jurisdiction. After the decision in Florida Prepaid,the
CAFC held that a counterclaim did not necessarily waive sovereign immunity. 85 In
State Contracting& Engineering Corp. v. Florida,86 the defendant, Florida, was not
required to withdraw its counterclaims against State Contracting & Engineering to
preserve its right to assert sovereign immunity as a defense.8 7 The CAFC held that a
defendant's failure to withdraw counterclaims while invoking sovereign immunity
after the Florida Prepaid decision did not constitute a waiver of sovereign
immunity.88 The CAFC reasoned that Florida had a reasonable expectation that its
actions, before the decision in Florida Prepaid,did not waive sovereign immunity
and, therefore, even after the decision in Florida Prepaid, the CAFC found no
89
waiver.
It is clear that when a state voluntarily submits to federal court jurisdiction, the
state waives its Eleventh Amendment rights. 90 Historic case law precedent indicates
some of the state actions that constitute a waiver of Eleventh Amendment rights
such as filing a suit in federal court or removing a case from state court to federal
court. 91 Until the decision in Florida Prepaid, however, a state could not have
92
reasonably expected to succeed with an Eleventh Amendment immunity defense.
80 Stewart, 393 F.3d at 487.
81 Id.
82 Id.
83Id.
84Id.at

488.
Contracting & Eng'g. Corp. v. Florida, 258 F.3d 1329, 1337 (Fed. Cir. 2001).
86 258 F.3d 1329 (Fed. Cir. 2001).
87Id
85 State

88 Id.
89 Id.

90Lapides v. Bd. of Regents of the Univ. Sys. of Ga., 535 U.S. 613, 619 (2002) (citing Clark v.
Barnard, 108 U.S. 436, 447 (1883)).
91Lapideo, 535 U.S. at 620 (removing to federal court); Clark, 108 U.S. at 447-48 (filing in
federal court).
92State Contracting & Eng'g. Corp. v. Florida, 258 F.3d 1329, 1337 (Fed. Cir. 2001).
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Therefore, pre-FloridaPrepaid,a state filing counterclaims in a patent infringement
action did not voluntarilysubmit itself to federal court jurisdiction per se. Currently,
post-Florida Prepaid,states have a reasonable expectation that filing compulsory
counterclaims in federal court is a voluntarily submission to federal court
93
jurisdiction.

C. Waiver by States' General Conduct
Although some specific state actions waive Eleventh Amendment immunity in
patent litigation, general conduct (conduct not specific to pending litigation) does not
waive Eleventh Amendment immunity for states. 94
The CAFC, in Xeehem
InternationalInc. v. University of Texas,95 explained that the university's active
participation in the patent system did not constructively waive the university's
sovereign immunity. 96 Xechem and the University entered into a Sponsored
Laboratory Study Agreement ("the Agreement") in 1995. 97 The Agreement included
terms that indicated that Xechem would provide financial and technical support for a
study to increase the solubility and therefore the effectiveness of a cancer drug,
paclitaxel. 98 Originally, the patent named Dr. Pandey of Xechem and Dr. Anderson
of the University as the inventors of a patent. 99 The university objected to the patent
naming Dr. Pandey as a co-inventor of the patent, and Dr. Pandey subsequently
wrote a letter recognizing Dr. Anderson as the sole inventor.100 Later in 1997,
Xechem and the University entered into a Patent and Technology Licensing
Agreement.1 01 This agreement gave exclusive rights for a license to manufacture and
market paclitaxel to Xechem for a payment of a continuing sum and a royalty to the
University.10 2 In 2000, the University notified Xechem that it had terminated the
Licensing agreement because of Xechem's alleged insolvency.103 The University also
informed Xechem that it no longer had the right to manufacture and market
paclitaxel.10 4 Xechem then filed suit seeking correction of inventorship against the
University.10 5 Finally, the CAFC concluded that the University had not waived its
sovereign immunity and found in favor of the University's affirmative defense of
106
sovereign immunity.
The CAFC further supported its specific conduct requirement for a state's
Eleventh Amendment immunity waiver in Tegie Communications Corp. v. Board of
93 Id.
94 Xechem Int'l Inc. v. Univ. of Tex. M.D. Anderson Cancer Ctr., 382 F.3d 1324, 1330 (Fed. Cir.
2004).
95 382 F.3d 1324 (Fed. Cir. 2004).

96

d

97 Id. at 1327.
98 Id.
99 Id.
100 Id.

101Id.

105

Id.
Id.
Id.
Id.

10

Id.

102

103
104
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Regents of the University of Texas. 107 In Tegie, the University of Texas brought an
action against a number of cellular communication companies for infringement of a
character pattern recognition apparatus.1 08 The CAFC indicated that Texas may
have waived its sovereign immunity with regard to the forty-eight companies it had
filed infringement suit against. 109 Texas, however, did not name Tegic in the suit. 110
Therefore, Texas did not waive its sovereign immunity with respect to a suit brought
against Texas by Tegic in the United States District Court for the Western District of
Washington. 111
More recently, the decision of Biomedical Patent Management Corporation v.
Departmentof Health Services 112 establishes further limitations on whether a state's
active conduct constitutes a waiver of sovereign immunity. 113 BPMC and DHS were
involved with three separate suits disputing a BPMC patent in two different
courts. 114
DHS had previously been involved in litigation with BPMC over a
disputed patent in 1997.115 In one case, DHS had waived its sovereign immunity by
choosing to initiate a patent suit against BPMC in federal court. 116 Here, the CAFC
107 458 F.3d 1335, 1344-45 (Fed. Cir. 2006). The court negated the argument that a state's
voluntary participation in activities controlled by federal statute imposes consent to suit arising
from those activities. Id. at 1339. See College Savings Bank, 527 U.S. 666, 667 (1999) (holding that
a state does not constructively waive state sovereign immunity because it undertakes conduct that
would traditionally be performed by private citizens).
108 Tegic, 458 F.3d at 1337.
109 Id.
1337 n. 2 (indicating the consolidation of cases under the caption Bd. of Regents the
Univ. of Tex. v. Alcatel, No. A-05-CA-181-SS (W.D.Tex. Oct. 4, 2005)). "Although here the
University obviously 'made itself a party to the litigation to the full extent required for its complete
determination,' it did not thereby voluntarily submit itself to a new action brought by a different
party in a different state and a different district court." Tegic, 458 F.3d at 1343 (quoting Clark v.
Barnard, 108 U.S. 436, 448 (1883)).
110 Tegie, 458 F.3d at 1344.
1 1Id. at 1344-45. The CAFC,in Tegic, indicates a state may control where itmay be sued. Id.
at 1342. Tegic was not an original party to the suit, thus distinguishing that case from Regents of
the University of Caliarnia v.El Lilly & Co., 119 F.3d 1559 (Fed.Cir. 1997). In Lilly, Lilly had an
action pending when it sought removal from the Northern District of California to the Southern
District of Indiana. Id. at 1563. Tegic, however, was not a party in the suit involving Texas. Tegic,
458 F.3d at 1342. "The court has stressed that a 'State's constitutional interest in immunity
encompasses not merely whether it may be sued, but where it may be sued."' Id. (quoting Pennhurst
State Sch. & Hosp. v. Halderman, 465 U.S. 89, 99 (1984)). Therefore, the Texas waiver of sovereign
immunity would not continue in the Tegic action because the Tegic action was brought by a new
party in a new forum, the United States District Court for the Western District of Washington.
Tegic, 458 F.3d at 1342. Texas's suits against the other forty-eight cellular phone companies were
pending in the Western District of Texas. I'd.
112 505 F.3d 1328 (Fed. Cir. 2007), petition for cert. filed, 76 U.S.L.W. 3410 (U.S.Jan.22, 2008)
(No. 07-956).
113 Id. at 1341.
1M Id. at 1331-32. The United States District Court for the Northern District of California
dismissed the 1997 case because of improper venue. Id. at 1331. Later, in 1998, BPMC brought an
action in a the Southern District of California charging DHS with infringing the same patent
disputed and dismissed because of improper venue in 1997, and the 1998 action was dismissed
based on DHS's affirmative defense of sovereign immunity. Id. Finally, in 2006, BPMC brought an
action in the Northern District of California against DHS and the CAFC dismissed the case after
DHS's affirmative defense of sovereign immunity. Id. at 1332.
115 Id. at 1331 (noting the dismissal under the case name Kalseri Found. Health Plan, Inc. v.
BiomedicalPatentMgmt. Corp., 194 F.3d 1327, 1343 (Fed. Cir. 1998)).
116BiomedicalPatent, 505 F.3d at 1333.

The John Marshall Review of Intellectual Property Law

[8:1 2008]

states that it "does not mean to draw a bright-line rule whereby a State's waiver of
sovereign immunity can never extend to a re-filed or separate lawsuit."'11 The
holdings in Tegic and BiomedicalPatent,however, appear to do just that. The CAFC
indicated that a state's waiver of sovereign immunity does not extend to another
118
action simply because it involves the same subject matter and the same parties.
More specifically the CAFC's use of the terms "case at hand" and "Eleventh
Amendment immunity" provide an indication that a state's waiver of sovereign
immunity only extends to the case in which the immunity has been waived. 119 To
hold otherwise would be inconsistent within the case. 120 The CAFC indicated such
narrow parameters for the waiver of sovereign immunity that the waiver only
applied in the same action and not in separate cases. 121 In conclusion, the holdings
in Tegie and Biomedical Patentindicate that a state's waiver of sovereign immunity
is only valid in the suit if a state clearly expresses intent to waive such immunity.
After the decision in Biomedical Patent, BPMC filed a petition for a writ of
certiorari to the Supreme Court. 122 BPMC asked the Supreme Court to determine if
a state must affirmatively waive sovereign immunity for each case it is involved in
regardless of the preceding circumstances of litigation. 123 BPMC also asked the
Court to determine if a state was constructively waiving its sovereign immunity by
actively participating in the federal patent system through the enforcement of its
own patent rights. 124 The Court has not yet acted on BPMC's petition.

II. ANALYSIS
The analysis section explores current decisions regarding Eleventh Amendment
sovereign immunity in patent cases. First, it analyzes whether a state must
affirmatively waive sovereign immunity to effectuate waiver. Then, it explores the
effect of active participation in the federal patent system with regard to waiver of
sovereign immunity.

A. States Have Many Advantages in the FederalPatentSystem
The Supreme Court has established that a state can waive its Eleventh
Amendment sovereign immunity by consenting to litigation in federal court or by
117

Id. at 1339.

8
11
Id. at 1335-36.
119 Id.at 1336.

120

Id.

see also Lapides v. Bd. of Regents of the Univ. Sys. of Ga., 535 U.S. 613, 619 (2002)
(indicating the court would be inconsistent to allow states to invoke jurisdiction in the same case in
which that state had waived sovereign immunity).
122Petition for Writ of Certiorari, Biomedical Patent Mgmt. Corp. v. Cal. Dept. of Health
Servs., No. 07-596 (U.S. filed Jan 22, 2008).
123 Id. at i ("Whether a state's waiver of Eleventh Amendment immunity in one action extends
to a subsequent action involving the same parties and the same underlying transaction or
occurrence.").
124 Id. ("Whether a state waives its Eleventh Amendment immunity in patent actions by
regularly and voluntarily invoking federal jurisdiction to enforce its own patent rights.").
121Id;
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bringing an action in federal court. 125 The Supreme Court, however, has not
addressed the extent of the waiver of immunity for a separate suit disputing issues
raised in previous litigation, or the effect of a waiver in a previous suit that was
dismissed without prejudice.
State agencies that invoke federal jurisdiction in patent litigation and claim
Eleventh Amendment immunity in similar patent litigation are acting
inconsistently. 126 These agencies' inconsistent actions lead to seriously unfair results
in patent litigation. 127 Additionally, the Supreme Court has indicated that the
results are unfair if a system allows one party to invoke federal jurisdiction in some
cases when it is an advantage and the party can claim immunity when it is an
advantage. 1 28 This system would allow a party, in this case a state agency, to receive
all of the benefits of the "Judicial power of the United States" without any
consequences for the judicial power. 129 A system that allows a party to receive the
benefits of a system but not be subject to the consequences of the system is
130
inherently unfair.
Many states currently rely on the Eleventh Amendment during patent litigation,
but California recently became the most active state with respect to patent
litigation. 131 The state of California alone has received judgments and settlements
from patent infringement litigation worth over $900 million since 2000.132 California
also derives a significant amount of revenue from licensing agreements, and
California's threat of active litigation often enhances those agreements. 133 Private
entities, however, have not been able to enforce patent rights against California
because of California's faithful reliance on Eleventh Amendment sovereign immunity
to patent infringement litigation. 134
The Supreme Court has noted its concern within the patent system about state
entities acting as non-practicing entities ("NPEs")-companies acquiring patents
merely to collect licensing fees. 135 For example, in Genentech Inc. v. Regents of the
University of California,136 the CAFC focused great attention on the University of
California's creation of the case or controversy that is only subject to federal court
jurisdiction and concerns a federally created property right for the University of
California. 137 The CAFC concluded that even though the University of California did
not consent to the declaratory action brought by Genentech, the University of
California enabled the actions by its deliberate acts. 138 The CAFC also placed
125
126

Clark v. Barnard, 108 U.S. 436, 447 (1883).
Lapides v. Bd. of Regents of the Univ. Sys. of Ga., 535 U.S. 613, 619 (2002).

127

Id,

128

Id.

129

Id.

130 Id.
131 Petition for Writ of Certiorari at 4, Biomedical Patent Mgmt. Corp. v. Cal. Dept. of Health
Servs., No. 07-596 (U.S. filed Jan 22, 2008).
132 Id.

1:3:3
Id. at

4-5.

Id. at 5 (indicating that the state of California has invoked sovereign immunity at least six
times since 1987).
135 See eBay Inc. v. MercExchange, L.L.C., 547 U.S. 388, 396 (Kennedy, J., concurring).
136 143 F.3d 1446 (Fed. Cir. 1998).
137 rId. at 1454.
138 Id.
134
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emphasis on the University of California's actions that were "not at the core of
educational/research purposes for which the University was chartered as an arm of
the state, although the record contains no basis for disputing that a research
university's patenting activity serves to move into the public benefit scientific
inventions that might otherwise languish as laboratory curiosities." 139 The CAFC
then chose not to address the question "whether there may be some state
instrumentalities that qualify as 'arms of the state' for some purposes but not
others." 140 Therefore, the current state of patent law allows for these state entities
acting as NPEs to operate lucrative patent machines with unfair tactical advantages.

B. States Do Not Enjoy as Many Advantages in Bankruptcy Litigation
1. The Supreme CourtHas Not Held That CongressLacks the Power to Abrogate
Eleven th Am en dm en t Imm unity.
Although the Supreme Court held that Congress did not have the power to
abrogate Eleventh Amendment immunity, with regard to patent litigation, in Florida
Prepaid,the Court specifically avoided holding that Congress did not have the power
to abrogate Eleventh Amendment immunity in bankruptcy litigation. 141
In 2006, the Supreme Court decided a bankruptcy case regarding Eleventh
Amendment immunity in Central Virginia Community College v. Katz. 142 In Katz,
the court appointed Katz as the liquidation supervisor for Wallace's Bookstore, Inc.
("Bookstore") in a chapter 11 bankruptcy. 143 Then, Katz initiated proceedings
against Virginia institutions of higher education (collectively "Virginia").144 Katz
sought to "avoid and recover alleged preferential transfers" from Bookstore to
Virginia after Bookstore became insolvent. 145 Then, Virginia responded with motions
to dismiss the proceedings on Eleventh Amendment immunity grounds. 146 After a
number of lower court decisions and appeals from those decisions, the Supreme Court
granted certiorari. 147 In its decision, the Court expressly avoided holding that
"Congress ha[d] abrogated States' immunity in proceedings to recover preferential
transfers." 148 Instead, the Court held that Congress' determination that States
should be amenable to chapter 11 bankruptcy proceedings is within the scope of
149
Congress' power to enact "Laws on the subject of Bankruptcies."

139Id.at 1453-54.
140
141

Id.at 1454 (quoting Regents of the Univ. of Cal. v. Doe, 519 U.S. 425, 428 n.2 (1997)).
Cent. Va. Cmty. Coll. v. Katz, 546 U.S. 356, 378-79 (2006).

142 Id.

113
Id. at
144 Id.

360.

145 Id.
146

Id.

147
148

Id. at 359.
Id. at 379.

149

Id.
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2. One Arm of a State's Waiver of Eleventh Amendment Immunity Imputes Waiver
on Other Arms of the State in BankruptcyLitigation.
Although the Supreme Court strives to apply Constitutional Amendments
consistently across all practices of law, the federal Circuit Courts of Appeals have not
applied the Eleventh Amendment issues in bankruptcy litigation consistently with
Eleventh Amendment issues in patent litigation. 150 The law consistently provides
protection, however, for patent infringement actions as well. 151 While in bankruptcy
actions the law protects parties from insurmountable debt, codified patent law
protects inventor's right to exclude in patent infringement actions. 152
Different state agencies within a state are separate entities within the state,
but, in some bankruptcy litigation, the court treats all state agencies as a single
entity with respect to Eleventh Amendment immunity. For example, the United
States Court of Appeals for the Second Circuit held, in In Re Charter Oak
Associates, 153 that the litigation conduct of one agency of the state was imputed to
another for the purpose of Eleventh Amendment waiver analysis in bankruptcy
litigation. 154 In Charter Oak, the Connecticut Department of Revenue Services sued
the operator of a mental health facility to collect unpaid taxes. 155 The Connecticut
Department of Social Services however, owed the operator a significant amount of
money. 156 After the Department of Revenue Services brought an action against the
operator, the operator brought an action against the Department of Social
Services. 157 The Second Circuit did not allow the Department of Social Services to
invoke the defense of sovereign immunity because the Department of Revenue
Services waived Connecticut's sovereign immunity by bringing the first action
158
against the operator.
Additionally, the United States Court of Appeals for the Tenth Circuit was
consistent with the Second Circuit's holdings in CharterOak in In Re Straight.159 In
Straight,Ms. Straight, as Centerline Traffic Control & Flagging, was doing business
as a Disadvantaged Business Enterprise ("DBE") in the state of Wyoming.160 Her
business became unprofitable and filed a petition for relief under Chapter 13 of the
Bankruptcy Code. 161 Shortly after the time of filing, the Wyoming Department of
Transportation ("WDOT") notified Straight of its intent to decertify Straight's
150 Compare In re Charter Oak Assocs., 361 F.3d 760, 772 (2d. Cir. 2004) (holding that one
state agency waived Eleventh Amendment sovereign immunity for all state agencies with respect to
one particular cause of action), andIn re Straight, 143 F.3d 1387, 1391 (10th Cir. 1998) (holding the
same), with Biomedical Patent Mgmt. Corp. v. Cal. Dep't. of Health Servs., 505 F.3d 1328, 1341
(Fed. Cir. 2007) (holding that there was a new cause of action in a separate venue in spite of having
the same factual circumstances with the same parties).
151 35 U.S.C § 271(e) (2006).
152
153

Id. § 271(a).

154

361 F.3d 760 (2d Cir. 2004).
CharterOak, 361 F.3d at 772 (2d Cir. 2004).

155

Id. at 763.

156

Id.

157

Id.

158

Id. at 772.

159 143 F.3d 1387 (10th Cir. 1998).
160 Id. at 1389.
161 Id.
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company of its DBE status. 162 About a month after the notification by WDOT,
WDOT decertified Straight because she had lost her ability to control the financial
capacity of her firm as required by DBE Definition 1.A(b).163 Straight then filed a
show cause order in the bankruptcy court for a contempt citation. 164 The bankruptcy
court issued an order against WDOT.165 WDOT did not appeal the order at first, but
then appealed the subsequent order approving the amount awarded Straight that
included an award of attorney's fees. 166 WDOT argued that the bankruptcy court did
not have jurisdiction over it.167 The Tenth Circuit held that proof of a claim by the
Wyoming Department of Employment and the Wyoming Workers' Safety and
Compensation Division against Straight had waived Wyoming's Eleventh
Amendment sovereign immunity. 168
The Second and Tenth Circuits have decided bankruptcy cases consistently,
indicating that the litigation conduct of one arm of a state imputes waiver of
Eleventh Amendment immunity to all other arms in a particular litigation. 169 In
order to remain constant, it is reasonable to believe that bankruptcy litigation is
analogous to patent litigation for the purposes of Eleventh Amendment waiver
analysis.170 Although the Supreme Court has held that the waiver of one state
agency imputes waiver on all other arms of the state in a particular litigation in
bankruptcy litigation, the Court has not ruled on whether the actions of one state
agency waive Eleventh Amendment sovereign immunity for all other agencies of the
same state in patent litigation.

III. PROPOSAL
This section explains how the Supreme Court should level the playing field
between state agencies and private entities with respect to federal patent law. First,
the Court should decide the waiver of sovereign immunity by a state in one case
waives sovereign immunity in all other cases between the state and the original
party with regard to a disputed patent. 171 Then, the Court should decide a state's
active participation in the federal patent system waives sovereign immunity in all
172
patent litigation.

162Id.
163

Id.

Id.
Id.
100 Id.
10;7 Id.
18 Id. at 1392.
1069
In re Charter Oak Assocs., 361 F.3d 760, 772 (2d Cir. 2004); Straight, 143 F.3d 1387, 1391
(10th Cir. 1998).
170
Reply Brief for Petitioner-Appellant at 22-23, Biomedical Patent Mgmt. Corp. v. State of
Cal., Dept. of Health Serv., No. 2006-1515 (U.S. Nov. 30, 2006).
171 Seo Petition for Writ of Certiorari at 10, Biomedical Patent,No. 07-956; Lapides v. Bd. of
Regents of the Univ. of Ga., 535 U.S. 613, 621 (2002) (indicating that the Supreme Court has
already held that state's can functionally waive Eleventh Amendment sovereign immunity by
removing an action to federal court because to hold otherwise would be unfair).
104

165

172

See id. at 20-21.
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A. A State's Waiver Of Eleventh Amendment Imm unity in One Case Should Apply
to a Later Case Involving the Same Parties Over the Same DisputedPatent.
A state's waiver of Eleventh Amendment immunity in one case should also apply
to all later cases involving the same disputed patent and parties. Indeed, this
application of Eleventh Amendment immunity ensures that states will not use the
benefits of sovereign immunity to pursue unfair and inconsistent results. 173
Today, the CAFC has indicated a need to apply the Eleventh Amendment in a
way that is consistent with the CAFC's concern about sovereign immunity's potential
unfair use. 174 For instance, in Biomedical Patent, the court indicated that a state
agency's waiver of Eleventh Amendment immunity did not extend from one action to
another action involving the same subject matter.1' 5 In fact, the CAFC's holding
increases the already significant advantage of state universities with its patent
rights. The Biomedical Patent decision indicates that a university may bring an
infringement action, voluntarily consenting to federal court jurisdiction, and if a
court dismisses the action, the university will have the privilege of a defense of
sovereign immunity in an action brought by the former defendant on the same
issues.1 7 6 This unfair and inconsistent use of the Eleventh Amendment was
addressed by the United States Court of Appeals for the Ninth Circuit in Hill v. Blind
Industries & Services,177 indicating that a rule of immunity that allows a state to
litigate on its own terms, "undermines the integrity of the judicial
system[,] ... wastes judicial resources, burdens jurors and witnesses, and imposes
substantial costs upon the litigants." 178 The Supreme Court subsequently reaffirmed
this policy of restricting a state's unfair advantage in patent litigation.17 9 Therefore,
the state's waiver of Eleventh Amendment immunity in one case should apply to all
later cases involving the same parties and the same disputed patent.

Petition for Writ of Certiorari at 23, Biomedical Patent,No. 07-956.
174
Biomedical Patent Mgmt. Corp. v. Cal. Dep't of Health Servs., 505 F.3d 1328, 1341 (Fed.
Cir. 2007), petition for cert, filed, 76 U.S.L.W. 3410 (U.S. Jan. 22, 2008) (No. 07-956). The holding
by the CAFC indicates that the unfairness or inconsistency that would arise from allowing DHS to
assert Eleventh Amendment Sovereign immunity would not be substantial enough to overcome the
general principles of waiver. Id. The litigation conduct by DHS did not demonstrate a clear intent
to waive sovereign immunity. Td.
175Id.at 1341.
176 Id.at 1339-40.
177 179 F.3d 754 (9th Cir. 1999).
178Id.at 756. Blind Industries & Services of Maryland ("BISM") contracted to purchase a large
portion of assets from Hill's business. Id Subsequently BISM failed to make payments to Hill, and
Hill brought an action against BISM for breach of contract and fraud. Id. BISM made two motions
to dismiss and neither of those motions mentioned Eleventh Amendment sovereign immunity. Id.
BISM conducted discovery and attended a pre-trial conference while never even mentioning the
Eleventh Amendment. Id. Then on the first day of trial, BISM asserted for the first time that it is
an arm of the state and thus the Eleventh Amendment bared Hill's action. Id. The United States
Court of Appeals for the Ninth Circuit eventually affirmed the district court's holding indicating
that BISM unequivocally consented to the jurisdiction of the federal court by its conduct in
appearing and actively litigating the case on the merits. Id. at 763. The holding also indicates that
an appellate court is not automatically barred from considering Eleventh Amendment defenses
asserted for the first time on appeal. Id. at 762.
17) Lapides v. Bd. of Regents of the Univ. of Ga., 535 U.S. 613, 620-21 (2002).
173
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B. A State s Active Participationin the FederalPatentSystem Should Constitute an
Action Sufficient to Waive Eleventh Amendment Imm unity in All PatentLitigation.
The Supreme Court, in Florida Prepaid, held that Congress did not validly
abrogate the State's sovereign immunity from infringement suits by the Patent
Remedy Act. 180 The Court, however, did not address the circumstances in which the
State waives its sovereign immunity.
One state agency's waiver of sovereign immunity should waive immunity for all
of that state's agencies. Many state universities have become very active in the
patent community. These universities' research and development programs create
and patent numerous inventions and technologies.1 81 The revenue generated by the
enforcement of each university's patent rights and licensing agreements helps fund
further research and development.18 2 Eleventh Amendment sovereign immunity,
however, prevents patent holders from successful infringement suits against state
agencies.18 3 During the research and development process, these universities are
free to infringe privately owned patents without any fear of infringement litigation.
One position is that sovereign immunity in the federal patent system does not
establish a significant advantage for state agencies because state agencies are
unlikely to steal or infringe patents on a large scale. 18 4 Proponents of this position
indicate that state agencies only infringe patents for research purposes and that the
18 5
research contributes to the promotion of science and the useful arts.
This policy, however, is contrary to the holding in Lapides.18 6 The double
standard allowing state universities to enforce patent rights and claim immunity
from patent rights against them creates a significant tactical advantage for state
universities in the federal patent system.18 7 For example, in California since 1987,
California has invoked sovereign immunity to obtain dismissal of at least six patent
actions.188 Meanwhile, from 2000 to 2006, California has obtained over $900 million
in judgments and settlements in patent infringement actions.18 9 This lucrative
patent strategy is precisely the unfair tactical advantage that the Supreme Court
prohibited in Lapides.190
180FloridaPrepaid,

527 U.S. 627, 647 (1999).
for Writ of Certiorari at 4, Biomedical Patent Mgmt. Corp. v. Cal. Dept. of Health
Servs., No. 07-596 (U.S. filed Jan 22, 2008).
182Id. at 4-5.
183 Florida Prepaid,527 U.S. at 647.
184 Christopher L. Beals, Comment, Review of the State Sovereignty Loophole in Intellectual
Property Rights Following FloridaPrepaidand College Savings, 9 U. PA. J. CONST. L. 1233, 1266
(2007). States, however, would probably not infringe patents on a large scale partly because of
economic and social factors. Id. at 1266.
185Id. at 1271-72.
186 Lapides v. Bd. of Regents of the Univ. of Ga., 535 U.S. 613, 624 (2002) (holding that a state's
action of removing a case to federal court waived Eleventh Amendment immunity).
187Id. at 614.
188Petition for Writ of Certiorari at 5, Biomedical Patent Mgmt. Corp. v. Cal. Dept. of Health
Servs., No. 07-596 (U.S. filed Jan. 22, 2008). "Since the implementation of the PACER system in the
district courts in the 1990s, at least 32 states have filed at least 173 affirmative patent actions." Id.
189Id. at 4.
Michael Ward, California's outside patent council, has indicated that the
University of California has begun, and plans to continue an aggressive enforcement strategy with
181 Petition

respect to patent litigation. Id. at 4-5.
190Lapides, 535 U.S. at 624.
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Furthermore, when state universities waive sovereign immunity by actively
participating in the federal patent system, all other state agencies should also waive
the sovereign immunity defense in patent litigation. In Biomedical Patent, DHS, a
state agency in California, invoked sovereign immunity and the CAFC dismissed the
action against DHS. 191 The University of California, however, had been very active
in enforcing its own patent rights. 192 The Second and Tenth Circuits have both
already established that the litigation conduct of one arm of a state is legally
indistinguishable from another.193 Therefore, the voluntary participation in the
federal patent system by the University should waive sovereign immunity for all of
the state agencies of California, including DHS.
State universities have used the federal patent system and the Eleventh
Amendment to benefit from all of the rights of a state agency as well as all of the
rights of a private patent holder. If state universities want to receive the patent
system benefits of acting as a private company, they should be subject to the same
infringement limitations as a private company.
Therefore, a state's active
participation in the federal patent system should constitute an action sufficient to
waive Eleventh Amendment immunity in all patent litigation.

CONCLUSION
The CAFC did hold correctly that DHS clearly waived sovereign immunity in the

1997 lawsuit. 194 The CAFC in Biomedical Patent, however, did not hold correctly
that DHS qualified for Eleventh Amendment Sovereign immunity by actively
participating in the 1997 lawsuit against BPMC and was free to invoke sovereign
immunity in the 2006 lawsuit between the same parties over the same patent. This
erroneous holding allows the inconsistent, unfair and prohibited use of the Eleventh
Amendment by states. 195 It allows states to forum shop for a court of its choosing or
not to litigate any patent issues at all. 196
Additionally, one state agency's conduct that constitutes waiver of sovereign
immunity should waive immunity for all other state agencies. Several Circuit Courts
of Appeals have held that the waiver of one arm of a state can waive sovereign
immunity for all other arms of the state in bankruptcy litigation. 197 The only reason
191Biomedical Patent Mgmt. Corp. v. Cal. Dept. of Health Servs., 505 F.3d 1328, 1341 (Fed.
Cir. 2007).
192
'93

Petition for Writ of Certiorari at 5, Biomedical Patent,No. 07-596.
In re Charter Oak Assocs., 361 F.3d 760, 772 (2d Cir. 2004); In re Straight, 143 F.3d 1387,

1391 (10th Cir. 1998).
194

BiomedicalPatent,505 F.3d at 1341.

Lapides, 535 U.S. at 614.
196 Petition for Writ of Certiorari at 13, BiomedicalPatent,No. 07-596. BPMC argues that the
removal to federal jurisdiction in Lapides was demonstrated the state's clear intent to waive
Eleventh Amendment sovereign immunity. Id. Likewise, the conduct of DHS, California's motion to
intervene in the 1997 action over BPMC's objection also demonstrated a clear intent to waive
immunity. Id.
197 See In -reCharter Oak Assocs., 361 F.3d 760, 772 (2d Cir. 2004); see also In re Straight, 143
F.3d 1387, 1392 (10th Cir. 1998) (indicating the actions of one arm of the state could waive Eleventh
Amendment Sovereign immunity for all other arms of the state in bankruptcy litigation that arose
out of the same transaction or occurrence).
195
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to deviate from consistent established law is when an area of law contains unique
circumstances that require a deviation. 198 Patent law does not contain any unique
circumstances that would require such a deviation. Therefore, sovereign immunity
analysis for patent litigation should remain consistent with the established sovereign
immunity analysis in bankruptcy litigation. The waiver of sovereign immunity
conduct by one state agency should waive immunity for all other state agencies.
Finally, the CAFC incorrectly held that a state's active participation in the
federal patent system does not waive sovereign immunity for the state with respect
to all patent litigation. In the interest of fairness, the courts should not allow a state
to exploit patents owned by private parties while avoiding the same consequences it
imposes on others. In conclusion, the courts should not allow states to use the
federal patent system as both a shield and a sword.

198 Lapides, 535

U.S. at 621.

